We are live on
!
Find out more
TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$4.08B
1-Year Est. Return
58.77%
This Fund
S&P 500
This Quarter
Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
(+38%)
Cap. Flow
+$2.17B
Cap. Flow
% of AUM
35.15%
Top 10 Holdings %
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$204M |
| 2 |
Microsoft
MSFT
|
+$195M |
| 3 |
Amazon
AMZN
|
+$97.4M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$95M |
| 5 |
TSMC
TSM
|
+$69.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$53M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$26.7M |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$23.7M |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$19.5M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27% |
| 2 | Healthcare | 10.88% |
| 3 | Consumer Discretionary | 10.71% |
| 4 | Financials | 8.69% |
| 5 | Communication Services | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4451
Lucid Diagnostics
LUCD
$185M
| $11K | ﹤0.01% |
+7,282
| New | +$18.1K |
|
|
MAXN
4452
DELISTED
Maxeon Solar Technologies
MAXN
| $11K | ﹤0.01% |
4
+3
| +300% | +$5.54K |
|
|
MREO
4453
Mereo BioPharma
MREO
$47.9M
| $11K | ﹤0.01% |
12,567
+233
| +2% | +$285 |
|
|
BINI
4454
DELISTED
Bollinger Innovations
BINI
| – | – |
0
| – | – |
|
|
NVVE
4455
DELISTED
Nuvve Holding Corp
NVVE
| – | – |
0
| – | – |
|
4456
P3 Health Partners
PIII
$35.9M
| $11K | ﹤0.01% |
47
-9
| -16% | -$2.25K |
|
4457
Quince Therapeutics
QNCX
$35M
| $11K | ﹤0.01% |
41
+19
| +86% | +$7.24K |
|
|
RBOT
4458
DELISTED
Vicarious Surgical
RBOT
| $11K | ﹤0.01% |
111
-130
| -54% | -$15.1K |
|
4459
Riley Exploration Permian
REPX
$796M
| $11K | ﹤0.01% |
578
-666
| -54% | -$16.3K |
|
4460
Riskified
RSKD
$850M
| $11K | ﹤0.01% |
2,825
+1,687
| +148% | +$7.91K |
|
|
RSVR
4461
Reservoir Media
RSVR
$656M
| $11K | ﹤0.01% |
2,249
-211
| -9% | -$1.35K |
|
4462
Safe Bulkers
SB
$787M
| $11K | ﹤0.01% |
4,296
-5,142
| -54% | -$17.4K |
|
4463
Sanara MedTech
SMTI
$314M
| $11K | ﹤0.01% |
354
-798
| -69% | -$22.3K |
|
4464
Security National Financial
SNFCA
$244M
| $11K | ﹤0.01% |
2,064
+2,004
| +3,340% | +$12.4K |
|
4465
Stantec
STN
$8.56B
| $11K | ﹤0.01% |
+242
| New | +$11.4K |
|
4466
Tactile Systems Technology
TCMD
$540M
| $11K | ﹤0.01% |
1,389
-50,075
| -97% | -$417K |
|
|
VBIO
4467
Valion Bio
VBIO
$713K
| $11K | ﹤0.01% |
5
+2
| +67% | +$6.76K |
|
4468
Ubiquiti
UI
$35B
| $11K | ﹤0.01% |
37
-285
| -89% | -$84.1K |
|
4469
Upexi
UPXI
$52.9M
| $11K | ﹤0.01% |
144
+74
| +106% | +$6.73K |
|
4470
Viemed Healthcare
VMD
$349M
| $11K | ﹤0.01% |
1,825
-9,575
| -84% | -$61.5K |
|
4471
Vanguard Global ex-US Real Estate ETF
VNQI
$3.52B
| $11K | ﹤0.01% |
292
+15
| +5% | +$651 |
|
4472
VerifyMe
VRME
$9.05M
| $11K | ﹤0.01% |
8,832
+2,902
| +49% | +$4.64K |
|
4473
Vanguard Total International Stock ETF
VXUS
$164B
| $11K | ﹤0.01% |
245
-801
| -77% | -$41K |
|
4474
Vanguard High Dividend Yield ETF
VYM
$84.1B
| $11K | ﹤0.01% |
116
-26,762
| -100% | -$2.78M |
|
4475
Weyco Group
WEYS
$434M
| $11K | ﹤0.01% |
548
-445
| -45% | -$11.3K |
|
Similar funds
CA
AP
BWA
JSW
GCM
ZP
SHCM
GCM
Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review
As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.
- Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
- Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
- Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
- Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
- Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
- Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
- Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.